1. Hosangadi D, Mine M, West CA, Selato R, et al.
   Non-communicable disease burden among adults with and without HIV in Botswana.
   AIDS 2026.
   


2. Wyen C, Jonsson-Oldenbuttel C, Noe S, Borch J, et al.
   Cabotegravir+rilpivirine long-acting every 2 months in a real-world setting: 24-month outcomes in people with HIV-1.
   AIDS 2026.
   


3. Sullivan K, Chatani-Gada M, Lievense B, Slack C, et al.
   Advancing ethical biomedical HIV prevention research for pregnant and lactating people: a collaborative approach.
   AIDS 2026.
   


4. Roush SM, Beck S, Coelho J, Chirwa A, et al.
   Mutational profiling of HIV+ diffuse large B-cell lymphoma reveals distinct mutational features with evidence of genomic instability.
   AIDS 2026.
   


5. Cholli PA, Zucker J, Vigil KJ, Minhaj FS, et al.
   Long-Term Mpox Sequelae 11 to 18 Months After Acute Illness : A Cohort Study in Two U.S. Cities.
   Ann Intern Med 2026.
   


6. Loveday M, Clarence E, Hlangu S, Singh N, et al.
   Pregnant women with MDR/RR-TB and the all-oral 6-month regimen: experiences from a patient series in South Africa.
   Clin Infect Dis 2026.
   


7. Sweetser B, Nguyen H, Dang H, Katumba D, et al.
   Evaluating the Cepheid Xpert TB/LTBI research-use-only assay for detection of active and latent Mycobacterium tuberculosis infection.
   Clin Infect Dis 2026.
   


8. Bunting SR, Vidyasagar N, Wang J, Shetty R, et al.
   Availability of Screening for Blood-Borne Viruses, Sexually Transmitted Infections, and HIV Pre-Exposure Prophylaxis (PrEP) at U.S. Substance Use Treatment Facilities Treating Stimulant Use Disorder.
   J Acquir Immune Defic Syndr 2026.
   


9. Ngcamphalala C, Yeo YR, I-Shin Su J, Jeetoo M, et al.
   Determining minimum resources required by Eswatini to meet its Ending the HIV Epidemic 2030 goal.
   J Acquir Immune Defic Syndr 2026.
   


10. Sauceda JA, Lisha N, Ahmed A, Wan F, et al.
    Anxiety symptom ratings before and during the interruption of antiretroviral therapy as part of HIV cure-related studies.
    J Acquir Immune Defic Syndr 2026.
    


11. LaCourse SM, Escudero JN, Whatney WE, Krish KN, et al.
    Mtb-specific CFP-10/ESAT-6 CD4 and CD8 T cell non-IFN-gamma+ responses are common in young Kenyan children despite low reported TB exposure.
    J Infect Dis 2026.
    


12. Sun J, Nidadavolu LS, Hsu HY, Rajagopal RG, et al.
    Mitochondrial DNA Fragment Dynamics in Acute and Chronic Human Immunodeficiency Virus: Insights From Human and Nonhuman Primate Models.
    J Infect Dis 2026.
    


13. Griffin DWJ, McMahon JH, Hoy JF.
    A call for equity in organ transplantation for people with HIV.
    Lancet 2026;407:222-223.
    


14. Agathis NT, Sato K, O'Connor S, Robaugh RIB, et al.
    Linking Children and Adolescents With TB Disease to HIV Services in 16 PEPFAR-supported High TB/HIV-Burden Countries in Sub-Saharan Africa, October 2018-September 2022.
    Pediatr Infect Dis J 2025.
    

Display articles in

• Abstract format